Loeb 2022.
Methods | Multicentre, randomised, non‐inferiority trial |
Participants | 1009 healthcare workers who provided direct care to patients with suspected or confirmed COVID‐19. Conducted in 29 healthcare facilities in Canada, Israel, Pakistan, and Egypt from 4 May 2020 to 29 March 2022. |
Interventions | Use of medical masks versus fit‐tested N95 respirators for 10 weeks, plus universal masking, which was the policy implemented at each site. |
Outcomes | The primary outcome was confirmed COVID‐19 on reverse transcriptase polymerase chain reaction (RT‐PCR) test. |
Notes | Financial support was given by the Canadian Institutes of Health Research, World Health Organization, and Juravinski Research Institute. Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-1966 |